CLOUDBREAK PHARMA INC. - B
(HKEX: 2592)
Cloudbreak Pharma, Inc. is an investment holding company, which engages in the research and development of therapeutic biologics. Its pipeline includes CBT-001, CBT-009, CBT-004, CBT-006, CBT-199, CBT-145, CBT-007, and CBT-011. The company was founded by Jin Song Ni, Van Son Dinh, and Jun Zhi Li in September 2015 and is headquartered in Irvine, CA.
8.220 -
-1.290
(-13.56%)
Range
7.350 - 9.580
(30.34%)
Open
9.500
Previous Close
9.510
Bid Price
8.220
Bid Volume
('000)
1
Ask Price
8.270
Ask Volume
('000)
1
Volume
('000)
4,984
Value
42,170,405
Remark
-
Delayed prices. Updated at 05 Dec 2025 14:53.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
